The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Immunological pathogenesis of inflammatory bowel disease
Open accessAbstract
Inflammatory bowel disease (IBD) is a chronic inflammatory state of the gastrointestinal tract and can be classified into 2 main clinical phenomena: Crohn's disease (CD) and ulcerative colitis (UC). The pathogenesis of IBD, including CD and UC, involves the presence of pathogenic factors such as abnormal gut microbiota, immune response dysregulation, environmental changes, and gene variants. Although many investigations have tried to identify novel pathogenic factors associated with IBD that are related to environmental, genetic, microbial, and immune response factors, a full understanding of IBD pathogenesis is unclear. Thus, IBD treatment is far from optimal, and patient outcomes can be unsatisfactory. As result of massive studying on IBD, T helper 17 (Th17) cells and innate lymphoid cells (ILCs) are investigated on their effects on IBD. A recent study of the plasticity of Th17 cells focused primarily on colitis. ILCs also emerging as novel cell family, which play a role in the pathogenesis of IBD. IBD immunopathogenesis is key to understanding the causes of IBD and can lead to the development of IBD therapies. The aim of this review is to explain the pathogenesis of IBD, with a focus on immunological factors and therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Colombel, J. F., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rachmilewitz, D., Lichtiger, S., D'Haens, G., Diamond, R. H., Broussard, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904492 · Cited by 3,143
Ford Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,021
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Self-citationReduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277
Zhou, L., Ivanov, I. I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D. E., Leonard, W. J., & Littman, D. R. (2007) · Nature Immunology · doi:10.1038/ni1488 · Cited by 2,141
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
Inflammatory bowel disease: clinical aspects and established and evolving therapies
Baumgart, D. C., & Sandborn, W. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60751-x · Cited by 1,920
Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1496 · Cited by 1,857
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Ivanov, I. I., Frutos, R. D. L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B., & Littman, D. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.009 · Cited by 1,770
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.017 · Cited by 1,586
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells
Yang, X. O., Panopoulos, A. D., Nurieva, R., Chang, S. H., Wang, D., Watowich, S. S., & Dong, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c600321200 · Cited by 1,490
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J. K. M., Doherty, J. M., Mills, J. C., & Colonna, M. (2009) · Nature · doi:10.1038/nature07537 · Cited by 1,251
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Bloomgren, G., Richman, S., Hotermans, C., Subramanyam, M., Goelz, S., Natarajan, A., Lee, S., Plavina, T., Scanlon, J. V., Sandrock, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107829 · Cited by 1,242
Self-citationIL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00243-6 · Cited by 1,203
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
Sandborn, W. J., Gasink, C., Gao, L.-L., Blank, M. A., Johanns, J., Guzzo, C., Sands, B. E., Hanauer, S. B., Targan, S., Rutgeerts, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203572 · Cited by 1,134
Danese, S., & Fiocchi, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1102942 · Cited by 1,102
Satoh-Takayama, N., Vosshenrich, C. A. J., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J.-J., Thiam, K., Cerf-Bensussan, N., Mandelboim, O., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.11.001 · Cited by 1,095
ATP drives lamina propria TH17 cell differentiation
Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., Yagita, H., Ishii, N., Evans, R., Honda, K., et al. (2008) · Nature · doi:10.1038/nature07240 · Cited by 1,089 · cited 1×
“Correspondingly, Th17 cell differentiation in the intestine is remarkably decreased in a germ-free system and in the presence of antibiotics.(56,57) Additionally, many studies have shown that specific gut microbiota drive Th17 cell differentiation.”
BackgroundKlose, C. S. N., Flach, M., Möhle, L., Rogell, L., Hoyler, T., Ebert, K., Fabiunke, C., Pfeifer, D., Sexl, V., Fonseca-Pereira, D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.03.030 · Cited by 1,080
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
Buonocore, S., Ahern, P. P., Uhlig, H. H., Ivanov, I. I., Littman, D. R., Maloy, K. J., & Powrie, F. (2010) · Nature · doi:10.1038/nature08949 · Cited by 1,067
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
Van Assche, G., Van Ranst, M., Sciot, R., Dubois, B., Vermeire, S., Noman, M., Verbeeck, J., Geboes, K., Robberecht, W., & Rutgeerts, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051586 · Cited by 1,060
Sonnenberg, G. F., Fouser, L. A., & Artis, D. (2011) · Nature Immunology · doi:10.1038/ni.2025 · Cited by 1,044
Peripheral education of the immune system by colonic commensal microbiota
Lathrop, S. K., Bloom, S. M., Rao, S. M., Nutsch, K., Lio, C.-W., Santacruz, N., Peterson, D. A., Stappenbeck, T. S., & Hsieh, C.-S. (2011) · Nature · doi:10.1038/nature10434 · Cited by 1,034
Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues
Bernink, J. H., Peters, C. P., Munneke, M., te Velde, A. A., Meijer, S. L., Weijer, K., Hreggvidsdottir, H. S., Heinsbroek, S. E., Legrand, N., Buskens, C. J., et al. (2013) · Nature Immunology · doi:10.1038/ni.2534 · Cited by 1,006
Chaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J.-M., Jack, R. S., Wunderlich, F. T., Brüning, J. C., Müller, W., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.018 · Cited by 980
Panaccione, R., Ghosh, S., Middleton, S., Márquez, J. R., Scott, B. B., Flint, L., van Hoogstraten, H. J. F., Chen, A. C., Zheng, H., Danese, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.052 · Cited by 963
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Colombel, J. F., Enns, R., Feagan, B. G., Hanauer, S. B., Lawrance, I. C., Panaccione, R., Sanders, M., Schreiber, S., Targan, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043335 · Cited by 927
Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System
Garrett, W. S., Lord, G. M., Punit, S., Lugo-Villarino, G., Mazmanian, S. K., Ito, S., Glickman, J. N., & Glimcher, L. H. (2007) · Cell · doi:10.1016/j.cell.2007.08.017 · Cited by 918
Fuchs, A., Vermi, W., Lee, J. S., Lonardi, S., Gilfillan, S., Newberry, R. D., Cella, M., & Colonna, M. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.010 · Cited by 907
TGF-β: A Master of All T Cell Trades
Li, M. O., & Flavell, R. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.025 · Cited by 893
Sanos, S. L., Bui, V. L., Mortha, A., Oberle, K., Heners, C., Johner, C., & Diefenbach, A. (2009) · Nature Immunology · doi:10.1038/ni.1684 · Cited by 847
Tiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H. A., Wirtz, S., Becker, C., Atreya, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16432 · Cited by 828
Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis
Mortha, A., Chudnovskiy, A., Hashimoto, D., Bogunovic, M., Spencer, S. P., Belkaid, Y., & Merad, M. (2014) · Science · doi:10.1126/science.1249288 · Cited by 820
IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 family
Dinarello, C. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70518-x · Cited by 819
Mechanisms of action of cyclosporine
Matsuda, S., & Koyasu, S. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00192-2 · Cited by 812
Natalizumab for Active Crohn's Disease
Ghosh, S., Goldin, E., Gordon, F. H., Malchow, H. A., Rask-Madsen, J., Rutgeerts, P., Vyhnálek, P., Zádorová, Z., Palmer, T., & Donoghue, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020732 · Cited by 808
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S., Panes, J., Vranic, I., Su, C., Rousell, S., & Niezychowski, W. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112168 · Cited by 800
Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria
Hepworth, M. R., Monticelli, L. A., Fung, T. C., Ziegler, C. G. K., Grunberg, S., Sinha, R., Mantegazza, A. R., Ma, H.-L., Crawford, A., Angelosanto, J. M., et al. (2013) · Nature · doi:10.1038/nature12240 · Cited by 778
A protective function for interleukin 17A in T cell–mediated intestinal inflammation
O'Connor Jr, W., Kamanaka, M., Booth, C. J., Town, T., Nakae, S., Iwakura, Y., Kolls, J. K., & Flavell, R. A. (2009) · Nature Immunology · doi:10.1038/ni.1736 · Cited by 756
Sandborn, W. J., Feagan, B. G., Fedorak, R. N., Scherl, E., Fleisher, M. R., Katz, S., Johanns, J., Blank, M., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.014 · Cited by 753
Lymphoid tissue inducer–like cells are an innate source of IL-17 and IL-22
Takatori, H., Kanno, Y., Watford, W. T., Tato, C. M., Weiss, G., Ivanov, I. I., Littman, D. R., & O'Shea, J. J. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20072713 · Cited by 740
Regulation of inflammatory responses by IL-17F
Yang, X. O., Chang, S. H., Park, H., Nurieva, R., Shah, B., Acero, L., Wang, Y.-H., Schluns, K. S., Broaddus, R. R., Zhu, Z., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071978 · Cited by 739 · cited 3×
“It has also been reported that loss of IL-17F can improve the intestinal inflammatory response.(67) Thus, the focus of current IBD therapies is on blocking IL17A and IL-17F.”
BackgroundInfluentialCD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms
Maloy, K. J., Salaun, L., Cahill, R., Dougan, G., Saunders, N. J., & Powrie, F. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021345 · Cited by 739
Fallon, P. G., Ballantyne, S. J., Mangan, N. E., Barlow, J. L., Dasvarma, A., Hewett, D. R., McIlgorm, A., Jolin, H. E., & McKenzie, A. N. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051615 · Cited by 738
Xu, L., Kitani, A., Fuss, I., & Strober, W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6725 · Cited by 733
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
Feagan, B. G., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Koval, J., Wong, C. J., Hopkins, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422202 · Cited by 727
Role of cytokines in inflammatory bowel disease
Sanchez-Muñoz, F., Dominguez-Lopez, A., & Yamamoto-Furusho, J. K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4280 · Cited by 699
Innate Lymphoid Cells: Emerging Insights in Development, Lineage Relationships, and Function
Spits, H., & Cupedo, T. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075053 · Cited by 693
Vonarbourg, C., Mortha, A., Bui, V. L., Hernandez, P. P., Kiss, E. A., Hoyler, T., Flach, M., Bengsch, B., Thimme, R., Hölscher, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.017 · Cited by 676
IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
Geremia, A., Arancibia-Cárcamo, C. V., Fleming, M. P. P., Rust, N., Singh, B., Mortensen, N. J., Travis, S. P. L., & Powrie, F. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101712 · Cited by 640
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial
Targan, S. R., Feagan, B. G., Fedorak, R. N., Lashner, B. A., Panaccione, R., Present, D. H., Spehlmann, M. E., Rutgeerts, P. J., Tulassay, Z., Volfova, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.024 · Cited by 614
Kamada, N., Hisamatsu, T., Okamoto, S., Chinen, H., Kobayashi, T., Sato, T., Sakuraba, A., Kitazume, M. T., Sugita, A., Koganei, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34610 · Cited by 603
Lepage, P., Häsler, R., Spehlmann, M. E., Rehman, A., Zvirbliene, A., Begun, A., Ott, S., Kupcinskas, L., Doré, J., Raedler, A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.011 · Cited by 597
Monteleone, G., Biancone, L., Marasco, R., Morrone, G., Marasco, O., Luzza, F., & Pallone, F. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70128-8 · Cited by 573
Pizarro, T. T., Michie, M. H., Bentz, M., Woraratanadharm, J., Smith, M. F., Foley, E., Moskaluk, C. A., Bickston, S. J., & Cominelli, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6829 · Cited by 572
CD4+ Lymphoid Tissue-Inducer Cells Promote Innate Immunity in the Gut
Sonnenberg, G. F., Monticelli, L. A., Elloso, M. M., Fouser, L. A., & Artis, D. (2011) · Immunity · doi:10.1016/j.immuni.2010.12.009 · Cited by 572
IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease
Kobayashi, T., Okamoto, S., Hisamatsu, T., Kamada, N., Chinen, H., Saito, R., Kitazume, M. T., Nakazawa, A., Sugita, A., Koganei, K., et al. (2008) · Gut · doi:10.1136/gut.2007.135053 · Cited by 570
Innate lymphoid cells regulate intestinal epithelial cell glycosylation
Goto, Y., Obata, T., Kunisawa, J., Sato, S., Ivanov, I. I., Lamichhane, A., Takeyama, N., Kamioka, M., Sakamoto, M., Matsuki, T., et al. (2014) · Science · doi:10.1126/science.1254009 · Cited by 568
Velayos, F. S., Terdiman, J. P., & Walsh, J. M. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41442.x · Cited by 548
The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome
Omenetti, S., & Pizarro, T. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00639 · Cited by 528
Rousseaux, C., Lefebvre, B., Dubuquoy, L., Lefebvre, P., Romano, O., Auwerx, J., Metzger, D., Wahli, W., Desvergne, B., Naccari, G. C., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041948 · Cited by 526
Murch, S. H., Braegger, C. P., Walker-Smith, J. A., & MacDonald, T. T. (1993) · Gut · doi:10.1136/gut.34.12.1705 · Cited by 520
Mouse models of inflammatory bowel disease☆
WIRTZ, S., & NEURATH, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.07.003 · Cited by 507
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice
Ogawa, A., Andoh, A., Araki, Y., Bamba, T., & Fujiyama, Y. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.09.013 · Cited by 495
Effector T cell plasticity: flexibility in the face of changing circumstances
Murphy, K. M., & Stockinger, B. (2010) · Nature Immunology · doi:10.1038/ni.1899 · Cited by 482
Goto, Y., Panea, C., Nakato, G., Cebula, A., Lee, C., Diez, M. G., Laufer, T. M., Ignatowicz, L., & Ivanov, I. I. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.005 · Cited by 465
Critical role of IL-17 receptor signaling in acute TNBS-induced colitis
Zhang, Z., Zheng, M., Bindas, J., Schwarzenberger, P., & Kolls, J. K. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000218764.06959.91 · Cited by 465
Claudins regulate the intestinal barrier in response to immune mediators
Kinugasa, T., Sakaguchi, T., Gu, X., & Reinecker, H. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70351-9 · Cited by 463
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
Uhlig, H. H., Coombes, J., Mottet, C., Izcue, A., Thompson, C., Fanger, A., Tannapfel, A., Fontenot, J. D., Ramsdell, F., & Powrie, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5852 · Cited by 463
Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation
Kleinschek, M. A., Boniface, K., Sadekova, S., Grein, J., Murphy, E. E., Turner, S. P., Raskin, L., Desai, B., Faubion, W. A., de Waal Malefyt, R., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081712 · Cited by 460
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Vermeire, S., O'Byrne, S., Keir, M., Williams, M., Lu, T. T., Mansfield, J. C., Lamb, C. A., Feagan, B. G., Panes, J., Salas, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60661-9 · Cited by 452
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
Sandborn, W. J., Feagan, B. G., Wolf, D. C., D’Haens, G., Vermeire, S., Hanauer, S. B., Ghosh, S., Smith, H., Cravets, M., Frohna, P. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513248 · Cited by 452
Leppkes, M., Becker, C., Ivanov, I. I., Hirth, S., Wirtz, S., Neufert, C., Pouly, S., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.018 · Cited by 444
Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells
de Beaucoudrey, L., Puel, A., Filipe-Santos, O., Cobat, A., Ghandil, P., Chrabieh, M., Feinberg, J., von Bernuth, H., Samarina, A., Jannière, L., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080321 · Cited by 439
Huber, S., Schramm, C., Lehr, H. A., Mann, A., Schmitt, S., Becker, C., Protschka, M., Galle, P. R., Neurath, M. F., & Blessing, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6526 · Cited by 390
CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22
Longman, R. S., Diehl, G. E., Victorio, D. A., Huh, J. R., Galan, C., Miraldi, E. R., Swaminath, A., Bonneau, R., Scherl, E. J., & Littman, D. R. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140678 · Cited by 383
Gladiator, A., Wangler, N., Trautwein-Weidner, K., & LeibundGut-Landmann, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202924 · Cited by 382
Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease
Schreiber, S., Heinig, T., Thiele, H.-G., & Raedler, A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90692-4 · Cited by 372
Klotz, L., Burgdorf, S., Dani, I., Saijo, K., Flossdorf, J., Hucke, S., Alferink, J., Novak, N., Beyer, M., Mayer, G., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082771 · Cited by 354
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
Maxwell, J. R., Zhang, Y., Brown, W. A., Smith, C. L., Byrne, F. R., Fiorino, M., Stevens, E., Bigler, J., Davis, J. A., Rottman, J. B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.019 · Cited by 342
Li, Y., de Haar, C., Chen, M., Deuring, J., Gerrits, M. M., Smits, R., Xia, B., Kuipers, E. J., & van der Woude, C. J. (2010) · Gut · doi:10.1136/gut.2009.184176 · Cited by 339
Wessels, J. A. M., Huizinga, T. W. J., & Guchelaar, H.-J. (2007) · Rheumatology · doi:10.1093/rheumatology/kem279 · Cited by 337
Seiderer, J., Elben, I., Diegelmann, J., Glas, J., Stallhofer, J., Tillack, C., Pfennig, S., Jürgens, M., Schmechel, S., Konrad, A., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20339 · Cited by 329
Fuss, I. J., Becker, C., Yang, Z., Groden, C., Hornung, R. L., Heller, F., Neurath, M. F., Strober, W., & Mannon, P. J. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000194183.92671.b6 · Cited by 326
Powell, N., Walker, A. W., Stolarczyk, E., Canavan, J. B., Gökmen, M. R., Marks, E., Jackson, I., Hashim, A., Curtis, M. A., Jenner, R. G., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.008 · Cited by 324
Role of Th17 Cells in the Pathogenesis of Human IBD
Gálvez, J. (2014) · ISRN Inflammation · doi:10.1155/2014/928461 · Cited by 319
Mechanisms of Disease: the hygiene hypothesis revisited
Guarner, F., Bourdet-Sicard, R., Brandtzaeg, P., Gill, H. S., McGuirk, P., van Eden, W., Versalovic, J., Weinstock, J. V., & Rook, G. A. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0471 · Cited by 315
Pham, T. A. N., Clare, S., Goulding, D., Arasteh, J. M., Stares, M. D., Browne, H. P., Keane, J. A., Page, A. J., Kumasaka, N., Kane, L., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.08.017 · Cited by 305
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
Sandborn, W. J., Ghosh, S., Panes, J., Vranic, I., Wang, W., Niezychowski, W., Vermeire, S. A. R. A., Dewit, O., Peeters, H., Stehlik, J., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.01.029 · Cited by 300
Self-citationRole of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice
Wruck, C. J., Fragoulis, A., Gurzynski, A., Brandenburg, L.-O., Kan, Y. W., Chan, K., Hassenpflug, J., Freitag-Wolf, S., Varoga, D., Lippross, S., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.132720 · Cited by 283
Magri, G., Miyajima, M., Bascones, S., Mortha, A., Puga, I., Cassis, L., Barra, C. M., Comerma, L., Chudnovskiy, A., Gentile, M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2830 · Cited by 280
IL-10 and its related cytokines for treatment of inflammatory bowel disease
Li, M.-C. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i5.620 · Cited by 277
Increased Expression of IP-10, IL-8, MCP-1, and MCP-3 in Ulcerative Colitis
Uguccioni, M., Gionchetti, P., Robbiani, D. F., Rizzello, F., Peruzzo, S., Campieri, M., & Baggiolini, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65128-0 · Cited by 275
CD4 T-cell differentiation and inflammatory bowel disease
Zenewicz, L. A., Antov, A., & Flavell, R. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.03.002 · Cited by 266
Budesonide for induction of remission in Crohn's disease
Rezaie, A., Kuenzig, M. E., Benchimol, E. I., Griffiths, A. M., Otley, A. R., Steinhart, A. H., Kaplan, G. G., & Seow, C. H. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000296.pub4 · Cited by 260
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
Kobori, A., Yagi, Y., Imaeda, H., Ban, H., Bamba, S., Tsujikawa, T., Saito, Y., Fujiyama, Y., & Andoh, A. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0245-1 · Cited by 250
Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease
D'Haens, G., Geboes, K., Ponette, E., Penninckx, F., & Rutgeerts, P. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70027-1 · Cited by 246
Aminosalicylates for induction of remission or response in Crohn's disease
Lim, W.-C., Wang, Y., MacDonald, J. K., & Hanauer, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008870.pub2 · Cited by 239
Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease
Beltrán, C. J., Núñez, L. E., Díaz-Jiménez, D., Farfan, N., Candia, E., Heine, C., López, F., González, M. J., Quera, R., & Hermoso, M. A. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21175 · Cited by 238
IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease
MITSUYAMA, K., TOYONAGA, A., SASAKI, E., WATANABE, K., TATEISHI, H., NISHIYAMA, T., SAIKI, T., IKEDA, H., TSURUTA, O., & TANIKAWA, K. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06047.x · Cited by 236
Th1/Th17 Immune Response Is Induced by Mesenteric Lymph Node Dendritic Cells in Crohn's Disease
Sakuraba, A., Sato, T., Kamada, N., Kitazume, M., Sugita, A., & Hibi, T. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.049 · Cited by 230
Gu, F.-M., Li, Q.-L., Gao, Q., Jiang, J.-H., Zhu, K., Huang, X.-Y., Pan, J.-F., Yan, J., Hu, J.-H., Wang, Z., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-150 · Cited by 227
Cutting Edge: IL-23 Cross-Regulates IL-12 Production in T Cell-Dependent Experimental Colitis
Becker, C., Dornhoff, H., Neufert, C., Fantini, M. C., Wirtz, S., Huebner, S., Nikolaev, A., Lehr, H.-A., Murphy, A. J., Valenzuela, D. M., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2760 · Cited by 227
Interleukin-1β and the Autoinflammatory Diseases
Dinarello, C. A. (2009) · New England Journal of Medicine · doi:10.1056/nejme0811014 · Cited by 226
Lee, S.-Y., Lee, S. H., Yang, E.-J., Kim, E.-K., Kim, J.-K., Shin, D.-Y., & Cho, M.-L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135858 · Cited by 225
Self-citationMunneke, J. M., Björklund, A. T., Mjösberg, J. M., Garming-Legert, K., Bernink, J. H., Blom, B., Huisman, C., van Oers, M. H. J., Spits, H., Malmberg, K.-J., et al. (2014) · Blood · doi:10.1182/blood-2013-11-536888 · Cited by 225
Increased Expression of CCL20 in Human Inflammatory Bowel Disease
Kaser, A., Ludwiczek, O., Holzmann, S., Moschen, A. R., Weiss, G., Enrich, B., Graziadei, I., Dunzendorfer, S., Wiedermann, C. J., Mürzl, E., et al. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000018066.46279.6b · Cited by 212
Macrophage-derived IL-18–mediated intestinal inflammation in the murine model of Crohn's disease
Kanai, T., Watanabe, M., Okazawa, A., Sato, T., Yamazaki, M., Okamoto, S., Ishii, H., Totsuka, T., Iiyama, R., Okamoto, R., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.28021 · Cited by 203
Enhanced synthesis of neutrophil-activating peptide-I/interleukin-8 in active ulcerative colitis
Mahida, Y. R., Ceska, M., Effenberger, F., Kurlak, L., Lindley, I., & Hawkey, C. J. (1992) · Clinical Science · doi:10.1042/cs0820273 · Cited by 199
McAlindon, M. E., Hawkey, C. J., & Mahida, Y. R. (1998) · Gut · doi:10.1136/gut.42.2.214 · Cited by 193
Mitsuyama, K., Toyonaga, A., Sasaki, E., Ishida, O., Ikeda, H., Tsuruta, O., Harada, K., Tateishi, H., Nishiyama, T., & Tanikawa, K. (1995) · Gut · doi:10.1136/gut.36.1.45 · Cited by 186
Glatzer, T., Killig, M., Meisig, J., Ommert, I., Luetke-Eversloh, M., Babic, M., Paclik, D., Blüthgen, N., Seidl, R., Seifarth, C., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.013 · Cited by 181
Wyant, T., Leach, T., Sankoh, S., Wang, Y., Paolino, J., Pasetti, M. F., Feagan, B. G., & Parikh, A. (2015) · Gut · doi:10.1136/gutjnl-2014-307127 · Cited by 177
Reinisch, W., Hommes, D. W., Van Assche, G., Colombel, J.-F., Gendre, J.-P., Oldenburg, B., Teml, A., Geboes, K., Ding, H., Zhang, L., et al. (2006) · Gut · doi:10.1136/gut.2005.079434 · Cited by 175
Colitis-Associated Colorectal Cancer Driven by T-bet Deficiency in Dendritic Cells
Garrett, W. S., Punit, S., Gallini, C. A., Michaud, M., Zhang, D., Sigrist, K. S., Lord, G. M., Glickman, J. N., & Glimcher, L. H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.07.015 · Cited by 170
Van den Brande, J. M. H., Koehler, T. C., Zelinkova, Z., Bennink, R. J., te Velde, A. A., ten Cate, F. J. W., van Deventer, S. J. H., Peppelenbosch, M. P., & Hommes, D. W. (2007) · Gut · doi:10.1136/gut.2006.105379 · Cited by 170
Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt− lymphoid cells
Reynders, A., Yessaad, N., Vu Manh, T., Dalod, M., Fenis, A., Aubry, C., Nikitas, G., Escalière, B., Renauld, J. C., Dussurget, O., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.201 · Cited by 170
Fischer, A., Zundler, S., Atreya, R., Rath, T., Voskens, C., Hirschmann, S., López-Posadas, R., Watson, A., Becker, C., Schuler, G., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310022 · Cited by 169
Role of the Gut Microbiota in the Development and Function of Lymphoid Cells
Kamada, N., & Núñez, G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203100 · Cited by 166
Genetics of ulcerative colitis
Thompson, A. I., & Lees, C. W. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21375 · Cited by 165
Stallmach, A., Langbein, C., Atreya, R., Bruns, T., Dignass, A., Ende, K., Hampe, J., Hartmann, F., Neurath, M. F., Maul, J., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13813 · Cited by 165
Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis
Melgar, S., Yeung, M. M., Bas, A., Forsberg, G., Suhr, O. B., Öberg, Å., Hammarström, S., Danielsson, Å., & Hammarström, M. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02268.x · Cited by 160
Asquith, M. J., & Powrie, F. M. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101330 · Cited by 154
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
Rutgeerts, P. J., Fedorak, R. N., Hommes, D. W., Sturm, A., Baumgart, D. C., Bressler, B. L., Schreiber, S., Mansfield, J. C., Williams, M. B., Tang, M. T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301769 · Cited by 152
Reinisch, W., Gasché, C., Tillinger, W., Wyatt, J., Lichtenberger, C., Willheim, M., Dejaco, C., Waldhör, T., Bakos, S., Vogelsang, H., et al. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01288.x · Cited by 150
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer
Stolfi, C., Rizzo, A., Franzè, E., Rotondi, A., Fantini, M. C., Sarra, M., Caruso, R., Monteleone, I., Sileri, P., Franceschilli, L., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20111106 · Cited by 147
Regulatory T cells in inflammatory bowel disease
Boden, E. K., & Snapper, S. B. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328311f26e · Cited by 144
Biancheri, P., Brezski, R. J., Sabatino, A. D., Greenplate, A. R., Soring, K. L., Corazza, G. R., Kok, K. B., Rovedatti, L., Vossenkämper, A., Ahmad, N., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.002 · Cited by 132
Bailey, J. R., Bland, P. W., Tarlton, J. F., Peters, I. R., Moorghen, M., Sylvester, P. A., Probert, C. S., & Whiting, C. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052332 · Cited by 123
Zundler, S., Schillinger, D., Fischer, A., Atreya, R. N., López-Posadas, R., Watson, A. J. M., Neufert, C. F., Atreya, I., & Neurath, M. F. (2016) · Gut · doi:10.1136/gutjnl-2016-312439 · Cited by 119
Warnke, C., Menge, T., Hartung, H., Racke, M. K., Cravens, P. D., Bennett, J. L., Frohman, E. M., Greenberg, B. M., Zamvil, S. S., Gold, R., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.161 · Cited by 118
Ogino, T., Nishimura, J., Barman, S., Kayama, H., Uematsu, S., Okuzaki, D., Osawa, H., Haraguchi, N., Uemura, M., Hata, T., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.049 · Cited by 118
Proinflammatory cytokines underlying the inflammation of Crohnʼs disease
Strober, W., Zhang, F., Kitani, A., Fuss, I. J., & Fichtner‐Feigl, S. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328339d099 · Cited by 117
Allgayer, H. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.18.s2.1.x · Cited by 114
ZOTTO, B. D., Mumolo, G. M., Pronio, A., Montesani, C., Tersigni, R., & Boirivant, M. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02250.x · Cited by 104
S1P signaling: new therapies and opportunities
Gonzalez‐Cabrera, P. J., Brown, S. D. M., Studer, S. M., & Rosen, H. (2014) · F1000Prime Reports · doi:10.12703/p6-109 · Cited by 104
Role of gut microbiota in the control of energy and carbohydrate metabolism
Venema, K. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833a8b60 · Cited by 102
Hontecillas, R., Horne, W. T., Climent, M., Guri, A. J., Evans, C., Zhang, Y.-F., Sobral, B., & Bassaganya-Riera, J. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.75 · Cited by 100
Boehm, F., Martin, M. P., Kesselring, R., Schiechl, G., Geissler, E. K., Schlitt, H. J., & Fichtner‐Feigl, S. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-97 · Cited by 99
TH17 Cell Induction and Effects of IL-17A and IL-17F Blockade in Experimental Colitis
Schmidt, E. G. W., Larsen, H. L., Kristensen, N. N., Poulsen, S. S., Pedersen, A. M. L., Claësson, M. H., & Pedersen, A. E. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318286fa1c · Cited by 95
Rani, R., Smulian, A. G., Greaves, D. R., Hogan, S. P., & Herbert, D. R. (2011) · European Journal of Immunology · doi:10.1002/eji.201041135 · Cited by 92
The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice
Deguchi, Y., Andoh, A., Yagi, Y., Bamba, S., Inatomi, O., Tsujikawa, T., & Fujiyama, Y. (2006) · Oncology Reports · doi:10.3892/or.16.4.699 · Cited by 91
Involvement of interleukin-4 and -10 in inflammatory bowel disease
Nielsen, O. H., Koppen, T., Rüdiger, N., Horn, T. D., Eriksen, J., & Kirman, I. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02088746 · Cited by 91
CD4+CD25+ Regulatory T Cells Suppress Th17-Responses in an Experimental Colitis Model
Ogino, H., Nakamura, K., Ihara, E., Akiho, H., & Takayanagi, R. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1286-2 · Cited by 87
Herrlinger, K. R., Diculescu, M., Fellermann, K., Hartmann, H., Howaldt, S. M., Nikolov, R. K., Petrov, A., Reindl, W., Otte, J. ‐., Stoynov, S. G., et al. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.09.016 · Cited by 74
Ermann, J., Staton, T. L., Glickman, J. N., Malefyt, R. D. W., & Glimcher, L. H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408540111 · Cited by 73
Garrido‐Mesa, N., Utrilla, P., Comalada, M., Zorrilla, P., Garrido‐Mesa, J., Zarzuelo, A., Rodríguez‐Cabezas, M. E., & Gálvez, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.09.004 · Cited by 73
Collins, C. B., Aherne, C. M., McNamee, E. N., Lebsack, M. D. P., Eltzschig, H. K., Jedlicka, P., & Rivera–Nieves, J. (2011) · Gut · doi:10.1136/gutjnl-2011-300820 · Cited by 73
Grimm, M., & Doe, W. F. (1996) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780020204 · Cited by 69
Mitsuyama, K., Tomiyasu, N., Takaki, K., Masuda, J., Yamasaki, H., Kuwaki, K., Takeda, T., Kitazaki, S., Tsuruta, O., & Sata, M. (2006) · Mediators of Inflammation · doi:10.1155/mi/2006/26875 · Cited by 69
Wang, A. H., Lam, W.-J., Han, D.-Y., Ding, Y., Hu, R., Fraser, A. G., Ferguson, L. R., & Morgan, A. R. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.02.014 · Cited by 66
Mizuno, S., Mikami, Y., Kamada, N., Handa, T., Hayashi, A., Sato, T., Matsuoka, K., Matano, M., Ohta, Y., Sugita, A., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000105 · Cited by 62
Saba, J. D., & Degagné, É. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s43453 · Cited by 61
Maerten, P., SHEN, C., Colpaert, S. A., Liu, Z., Bullens, D. M. A., Assche, G. V., PENNINCKX, F. M., Geboes, K. J., Vanham, G. L., Rutgeerts, P., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02362.x · Cited by 55
Harnessing Regulatory T Cells for the Treatment of Inflammatory Bowel Disease
Geem, D., Harusato, A., Flannigan, K. L., & Denning, T. L. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000343 · Cited by 55
Vedolizumab for Ulcerative Colitis and Crohn’s Disease: Results and Implications of GEMINI Studies
Lam, M., & Bressler, B. L. (2014) · Immunotherapy · doi:10.2217/imt.14.66 · Cited by 48
Inhibition of IL-17 as a Pharmacological Approach for IBD
Fitzpatrick, L. R. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.821118 · Cited by 46
Suzuki, K., Yokoyama, J., Kawauchi, Y., Honda, Y., Sato, H., Aoyagi, Y., Terai, S., Okazaki, K., Suzuki, Y., Sameshima, Y., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw143 · Cited by 43
Fitzpatrick, L. R., Small, J. S., Doblhofer, R., & Ammendola, A. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192203 · Cited by 41
Feuerstein, J. D. (2016) · Annals of Gastroenterology · doi:10.20524/aog.2016.0032 · Cited by 39
Preclinical development of AMG 139, a human antibody specifically targeting IL ‐23
Köck, K., Pan, W., Gow, J. M., Horner, M. J., Gibbs, J. P., Colbert, A., Goletz, T. J., Newhall, K. J., Rees, W. A., Sun, Y., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12904 · Cited by 33
Nielsen, C. H., Albertsen, L., Bendtzen, K., et al. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03335.x · Cited by 29
Circulating Cytokines Reflect Mucosal Inflammatory Status in Patients with Crohn’s Disease
Ljuca, F., Gegic, A., Salkic, N. N., et al. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1016-9 · Cited by 26
Combined Blockade of IL-17A and IL-17F May Prevent the Development of Experimental Colitis
McLean, L. P., Cross, R. K., & Shea‐Donohue, T. (2013) · Immunotherapy · doi:10.2217/imt.13.87 · Cited by 24
The challenges of stratifying patients for trials in inflammatory bowel disease
Biancheri, P., Powell, N., Monteleone, G., Lord, G. M., & MacDonald, T. T. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.08.002 · Cited by 23
Mazur, M., Karczewski, J., Lodyga, M., et al. (2014) · Journal of Dermatological Treatment · doi:10.3109/09546634.2014.991267 · Cited by 20
Grim19 Attenuates DSS Induced Colitis in an Animal Model
Kim, J. K., Lee, S., Lee, S.-Y., Kim, E., Kwon, J.-E., Seo, H.-B., Lee, H. H., Lee, B., Park, S., & Cho, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155853 · Cited by 19
Self-citationCyclosporine A Regulates Pro-Inflammatory Cytokine Production in Ulcerative Colitis
Steiner, S., Daniel, C., Fischer, A., Atreya, I., Hirschmann, S., Waldner, M. J., Neumann, H., Neurath, M. F., Atreya, R. N., & Weigmann, B. (2014) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-014-0309-7 · Cited by 18
Cited by
Jang, D.-I., Lee, A.-H., Shin, H.-Y., Song, H.-R., Park, J.-H., Kang, T.-B., Lee, S.-R., & Yang, S.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052719 · Cited by 1,694
Self-citationHarrell, C. R., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019) · Cells · doi:10.3390/cells8121605 · Cited by 795
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Feagan, B. G., D’Haens, G., Wolf, D. C., Jovanovic, I., Hanauer, S. B., Ghosh, S., Petersen, A., Hua, S. Y., Lee, J. H., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2033617 · Cited by 569
Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases
Candelli, M., Franza, L., Pignataro, G., Ojetti, V., Covino, M., Piccioni, A., Gasbarrini, A., & Franceschi, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126242 · Cited by 397
Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels
Alam, M. T., Amos, G. C. A., Murphy, A. R. J., Murch, S., Wellington, E. M. H., & Arasaradnam, R. P. (2020) · Gut Pathogens · doi:10.1186/s13099-019-0341-6 · Cited by 380
Metadata
- Authors
- Lee, S. H., Kwon, J. E., & Cho, M.-L.
- Venue
- Intestinal Research
- Published
- 2018
- Volume
- 16
- Issue
- 1
- Pages
- 26
- ISSN
- 1598-9100 (ISSN-L)
- 2288-1956
- OpenAlex
- W2783494524
- Cited by
- 575
- References
- 181
- FWCI
- 26.24
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.